Hologic Announces Second Quarter Fiscal 2015 Financial Results

Hologic recorded a Generally Accepted Accounting Principles Earnings Per Share (GAAP EPS) of USD 0.17, a Non-GAAP EPS earnings per share of USD 0.41, and raised full-year revenue and earnings guidance. Non-GAAP earnings EPS rose to USD 0.41, an increase of 10.8%. Revenues grew in all Hologic business segments. International revenues declined to USD 160.3 million, but rose by 8.0%, on a constant currency basis.

Hologic develops, manufactures and supplies premium diagnostic and surgical products, and medical imaging systems for diagnostics, breast health, gynecology, surgical, and skeletal health.

Steve MacMillan, president and CEO of Hologic, said, "We posted strong organic revenue growth across the board for a second straight quarter, while profitability increased at an even faster rate. As a Company, we have come a long way in a short period of time. While we focus on continuing to improve our performance, we are increasingly confident in our people and products, and are therefore further raising our financial outlook for the year."

Related Links:
Hologic